Athira Pharma Price Patterns
| ATHADelisted Stock | USD 6.55 0.19 2.82% |
Momentum 81
Buy Peaked
Oversold | Overbought |
Using Athira Pharma hype-based prediction, you can estimate the value of Athira Pharma from the perspective of Athira Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Athira Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Athira because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Athira Pharma after-hype prediction price | USD 6.49 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Athira |
Athira Pharma After-Hype Price Density Analysis
As far as predicting the price of Athira Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Athira Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Athira Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Athira Pharma Estimiated After-Hype Price Volatility
In the context of predicting Athira Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Athira Pharma's historical news coverage. Athira Pharma's after-hype downside and upside margins for the prediction period are 0.32 and 16.53, respectively. We have considered Athira Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Athira Pharma is very risky at this time. Analysis and calculation of next after-hype price of Athira Pharma is based on 3 months time horizon.
Athira Pharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Athira Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Athira Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Athira Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.30 | 10.04 | 0.06 | 0.09 | 4 Events / Month | 7 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
6.55 | 6.49 | 0.92 |
|
Athira Pharma Hype Timeline
Athira Pharma is presently traded for 6.55. The entity has historical hype elasticity of -0.06, and average elasticity to hype of competition of 0.09. Athira is forecasted to decline in value after the next headline, with the price expected to drop to 6.49. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.92%, whereas the daily expected return is presently at 1.3%. The volatility of related hype on Athira Pharma is about 14140.85%, with the expected price after the next announcement by competition of 6.64. About 13.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.99. Some equities with similar Price to Book (P/B) outperform the market in the long run. Athira Pharma recorded a loss per share of 9.67. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 18th of September 2025. Given the investment horizon of 90 days the next forecasted press release will be in about 4 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.Athira Pharma Related Hype Analysis
Having access to credible news sources related to Athira Pharma's direct competition is more important than ever and may enhance your ability to predict Athira Pharma's future price movements. Getting to know how Athira Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Athira Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LPTX | LPTX Old | (0.05) | 20 per month | 6.90 | 0.14 | 25.00 | (9.43) | 65.13 | |
| CTXR | Citius Pharmaceuticals | 0.04 | 21 per month | 0.00 | (0.18) | 10.59 | (10.53) | 38.23 | |
| ICU | SeaStar Medical Holding | (0.05) | 8 per month | 0.00 | (0.19) | 9.58 | (9.88) | 34.66 | |
| APLM | Apollomics Class A | 1.49 | 3 per month | 9.27 | 0 | 17.08 | (14.50) | 44.38 | |
| MBRX | Moleculin Biotech | (0.50) | 9 per month | 0.00 | (0.20) | 9.37 | (11.73) | 41.63 | |
| CRIS | Curis Inc | (0.11) | 8 per month | 0.00 | (0.15) | 9.60 | (8.13) | 33.70 | |
| FBLG | FibroBiologics Common Stock | (0.02) | 9 per month | 8.24 | (0) | 14.71 | (12.82) | 47.13 | |
| LNAI | Lunai Bioworks | 0.05 | 8 per month | 0.00 | (0.01) | 12.62 | (8.82) | 55.92 | |
| ADTX | Aditxt Inc | (0.06) | 10 per month | 0.00 | (0.27) | 22.54 | (27.59) | 63.67 | |
| DARE | Dare Bioscience | (0.08) | 10 per month | 0.00 | (0.03) | 6.55 | (6.98) | 26.52 |
Athira Pharma Additional Predictive Modules
Most predictive techniques to examine Athira price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Athira using various technical indicators. When you analyze Athira charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Athira Pharma Predictive Indicators
The successful prediction of Athira Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Athira Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Athira Pharma based on analysis of Athira Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Athira Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Athira Pharma's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Athira Stock
If you are still planning to invest in Athira Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Athira Pharma's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |